Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05145257 · ClinicalTrials.gov registry record · NA

Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms

A NA study of Menstrual Pain and PMS, sponsored by Zenchi.

Completed
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT05145257 is a NA study of Menstrual Pain and PMS that has completed, run by Zenchi. The registered enrollment target is 68 participants, roughly in line with the 67-participant average among 3 other Menstrual Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05145257, a NA study of Menstrual Pain and PMS, has completed, sponsored by Zenchi.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms. It is hypothesized that the dietary supplement marketed as "Elix Cycle Balance" will improve subjective wellbeing in trial participants by alleviating common symptoms of PMS and menstrual symptoms, such as cramps, bloating, and mood swings. A total of 65 participants will be recruited for the trial following screening, with the expectation that at least 50 participants will complete the trial. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants. The total intervention study period will be 3 months.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Elix Cycle Balance

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2022-01-05
Est. Completion 2022-05-31
Phase NA

Sponsor

Zenchi

3 total trials

What the Registry Record Tells You About NCT05145257

The ClinicalTrials.gov registry entry for NCT05145257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 67-participant average among 3 other Menstrual Pain trials with a reported enrollment target. The listed sponsor is Zenchi, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Menstrual Pain appearing as the primary indexed condition, and to 1 intervention - of which Elix Cycle Balance is the first listed.

NCT05145257 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05145257 about?

NCT05145257 is a clinical study titled "Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms". This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms. It is hypothesized that the dietary supplement marketed as "Elix Cycle Balance" will improve subjective wellbeing...

What is the current status of trial NCT05145257?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2022-01-05. Estimated completion is 2022-05-31.

What conditions does trial NCT05145257 study?

This clinical trial studies the following conditions: Menstrual Pain, PMS.

What interventions are being tested in trial NCT05145257?

The interventions under investigation include: Elix Cycle Balance (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05145257?

This trial is sponsored by Zenchi, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05145257 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menstrual Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.